alpha-L-iduronidase
Senast uppdaterad 28 Jun 2022
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den IDUA gene provides instructions for producing an enzyme called alpha-L-iduronidase, which is essential for the breakdown of large sugar molecules called glycosaminoglycans (GAGs). Through a process called hydrolysis, alpha-L-iduronidase uses water molecules to break down a molecule known as unsulfated alpha-L-iduronic acid, which is present in two GAGs called heparan sulfate and dermatan sulfate. Alpha-L-iduronidase is located in lysosomes, compartments within cells that digest and recycle different types of molecules.
Videoval för GenesVideobibliotek
Normal function
Den IDUA gene provides instructions for producing an enzyme called alpha-L-iduronidase, which is essential for the breakdown of large sugar molecules called glycosaminoglycans (GAGs). Through a process called hydrolysis, alpha-L-iduronidase uses water molecules to break down a molecule known as unsulfated alpha-L-iduronic acid, which is present in two GAGs called heparan sulfate and dermatan sulfate. Alpha-L-iduronidase is located in lysosomes, compartments within cells that digest and recycle different types of molecules.
Conditions referring to this gene or chromosome
Other names
alpha-L-iduronidase
IDUA_HUMAN
Related patient information and medicines

Patient information leaflet
Polymorf ljusutslag
Polymorphic light. It looks like reddened skin with raised red spots or small blisters. It is generally itchy and uncomfortable. How common is polymorphic light eruption. Polymorphic light eruption (PMLE) mostly affects people aged 20-40 years. It is more common in women. These are: Special sunscreens with high UVA protection. Cream containing.

Patient information leaflet
Medicin mot högt blodtryck
For detailed information about your own medication you should read the leaflet that comes inside the medicine packet. Other medicines for high blood pressure Apart from th... For example: Spironolactone Spironolactone is another stronger 'water' tablet (diuretic) sometimes used as an add-on option for blodtryck which is difficult to control..

Patient information leaflet
Blod i sädesvätska
Hematospermi means there is blood in the semen. Inflammation of the tubes that carry sperm from the testicles (epididymo-orchitis) Epididymo-orchitis. The haem... Medicines If you have persistent haematospermia without an identified cause then a type of medicine called a 5-alpha reductase inhibitor such as finasteride Finasteride for prostate.

Patient information leaflet
Restless legs-syndrom
What is restless legs syndrome. Restless legs syndrome (RLS) is sometimes called Willis-Ekbom disease after the doctors who first described it. It is a condition where you have an urge to move your legs. Also after a time on dopamine agonist... If this is the case, you will need to stop or change your medication. Alpha-2-delta ligands This is.

Patient information leaflet
Kronisk prostatit
Prostatit means that you have inflammation of your prostate gland. There are two main types of prostatitis: short-lived (acute) or persiste... It may be that some antibiotics have anti-inflammatory properties as well or that they may clear some germs (bacteria) that are difficult to find when your urine is tested. Alpha-blockers Alpha-blockers -.

Patient information leaflet
Testikelcancer
Testikelcancer is a cancer that arises from a testicle (testis). Around half of all cases occur in men aged under 35 but testicular cancer rarely occurs before puberty. Another useful test i... The tumour markers commonly tested for are alpha-fetoprotein (AFP), beta human chorionic gonadotrophin (beta-hCG), lactic dehydrogenase (LDH) and.
Vidare läsning och referenser
- alpha-L-iduronidase; MedlinePlus, National Library of Medicine.
- Beesley CE, Meaney CA, Greenland G, Adams V, Vellodi A, Young EP, Winchester BG. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations. Hum Genet. 2001 Nov;109(5):503-11. doi: 10.1007/s004390100606. Epub 2001 Oct 19.
- Clarke LA. Mucopolysaccharidosis Type I. 2002 Oct 31 [updated 2025 Dec 4]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1162/
- Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr. 2004 May;144(5 Suppl):S27-34. doi: 10.1016/j.jpeds.2004.01.052. No abstract available.
- Pastores GM, Arn P, Beck M, Clarke JT, Guffon N, Kaplan P, Muenzer J, Norato DY, Shapiro E, Thomas J, Viskochil D, Wraith JE. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I. Mol Genet Metab. 2007 May;91(1):37-47. doi: 10.1016/j.ymgme.2007.01.011. Epub 2007 Mar 2.
- Terlato NJ, Cox GF. Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature. Genet Med. 2003 Jul-Aug;5(4):286-94. doi: 10.1097/01.GIM.0000078027.83236.49.
- Vijay S, Wraith JE. Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr. 2005 Jul;94(7):872-7. doi: 10.1111/j.1651-2227.2005.tb02004.x.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
28 Jun 2022 | Senaste versionen
1 Dec 2008 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

